Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: GeneNews; Accelr8; Atlas Antibodies, Gene Company

NEW YORK (GenomeWeb News) – GeneNews' shares began trading this week the Toronto Stock Exchange on a one-for-six consolidated basis, resultin in 33,744,883 issued and outstanding shares. The consolidation was previously announced on Dec. 7 and was approved by the company's shareholders in April.


Accelr8 Technology began trading on the Nasdaq on Wednesday after moving from the New York Stock Exchange. Its stock trades under the ticker symbol "AXDX," and on its website the company has also begun calling itself Accelerate Diagnostics.


Atlas Antibodies has chosen Hong Kong-based firm Gene Company to distribute its polyclonal and monoclonal antibodies for research use in China, Hong Kong, and Macau.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.